Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
The FDA has advised consumers not to use albuterol sulfate inhalation solution, 0.083%, and ipratropium bromide inhalation solutions, 0.02%, unit-dose vials, purchased after September 8, 2009 and manufactured by Dey L.P., a subsidiary of Mylan, because the medications might have been part of a shipment being transported on a stolen tractor-trailer. The stolen vials have not been recovered and may be dangerous to use because of improper storage and handling.
Although the FDA is not aware of any reports of adverse events, the agency is advising patients not to use their medication if it was received or purchased after Sept. 8, 2009 and is from one of the following lots:
Albuterol Sulfate Inhalation Solution (3mL vials; displays the brand name “Dey”)
- Lot # 9G04, NDC # 49502-697-29
- Lot # 9FD8, NDC # 49502-697-61
- Lot # 9FD9, NDC # 49502-697-61
- Lot # 9FE1, NDC # 49502-697-61
Ipratropium Bromide Inhalation Solution (2.5mL vials; displays the brand name “Dey”)
- Lot # F09089, NDC # 49502-685-31
- Lot # C09119, NDC # 49502-685-62
- Lot # C09120, NDC # 49502-685-62
For more information visit www.fda.gov/NewsEvents/PublicHealthFocus/ucm182091.htm.
